Gastroenterology
Volume 134, Issue 1 , Pages 204-214 , January 2008

Esophageal Remodeling Develops as a Consequence of Tissue Specific IL-5-Induced Eosinophilia

  • Anil Mishra

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Meiqin Wang

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Venkatarajani R. Pemmaraju

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Margaret H. Collins

      Affiliations

    • Division of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Patricia C. Fulkerson

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • J. Pablo Abonia

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Carine Blanchard

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Philip E. Putnam

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Marc E. Rothenberg

      Affiliations

    • Division of Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio
    • Corresponding Author InformationAddress requests for reprints to: Marc E. Rothenberg, MD, PhD, Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC 7028, Cincinnati, Ohio 45229. fax: (513) 636-3310.

Received 13 June 2007 ,Accepted 27 September 2007.

References 

  1. Bousquet J, Jeffery PK, Busse WW, et al. Asthma (From bronchoconstriction to airways inflammation and remodeling). Am J Respir Crit Care Med. 2000;161:1720–1745
  2. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma (An ultrastructural, quantitative study and correlation with hyperreactivity). Am Rev Respir Dis. 1989;140:1745–1753
  3. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517–525
  4. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164:S28–S38
  5. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax. 1998;53:21–27
  6. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669
  7. Aceves SS, Newbury RO, Dohil R, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:206–212
  8. Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90
  9. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003;125:1419–1427
  10. Furuta GT. Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr. 1998;26:468–471
  11. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206
  12. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004;113:11–29
  13. Justinich CJ, Ricci A, Kalafus DA, et al. Activated eosinophils in esophagitis in children: a transmission electron microscopic study. J Pediatr Gastroenterol Nutr. 1997;25:194–198
  14. Furuta G, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363
  15. Dahms BB. Reflux esophagitis: sequelae and differential diagnosis in infants and children including eosinophilic esophagitis. Pediatr Dev Pathol. 2004;7:5–16
  16. Kirsch R, Bokhary R, Marcon MA, et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;44:20–26
  17. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85–101
  18. Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev. 2001;179:163–172
  19. Martin LB, Kita H, Leiferman KM, et al. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol. 1996;109:207–215
  20. Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90
  21. Mishra A, Hogan SP, Brandt EB, et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168:2464–2469
  22. Mishra A, Hogan SP, Brandt EB, et al. Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking. J Biol Chem. 2002;277:4406–4412
  23. Fulkerson PC, Fischetti CA, McBride ML, et al. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci U S A. 2006;103:16418–16423
  24. Zhu Z, Lee CG, Zheng T, et al. Airway inflammation and remodeling in asthma (Lessons from interleukin 11 and interleukin 13 transgenic mice). Am J Respir Crit Care Med. 2001;164:S67–S70
  25. Sueyoshi S, Miyata Y, Masumoto Y, et al. Reduced airway inflammation and remodeling in parallel with mucin 5AC protein expression decreased by s-carboxymethylcysteine, a mucoregulant, in the airways of rats exposed to sulfur dioxide. Int Arch Allergy Immunol. 2004;134:273–280
  26. Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575
  27. Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338:1592–1600
  28. Straumann A, Rossi L, Simon HU, et al. Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?. Gastrointest Endosc. 2003;57:407–412
  29. Straumann A. Eosinophilic esophagitis: a novel entity?. Schweiz Rundsch Med Prax. 2006;95:191–195
  30. Parfitt JR, Gregor JC, Suskin NG, et al. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19:90–96
  31. Selman M, Thannickal VJ, Pardo A, et al. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs. 2004;64:405–430
  32. Pardo A, Selman M. Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem Cell Biol. 2002;34:1534–1538
  33. Glickman JN, Blount PL, Sanchez CA, et al. Mucin core polypeptide expression in the progression of neoplasia in Barrett’s esophagus. Hum Pathol. 2006;37:1304–1315
  34. Zhu Z, Ma B, Zheng T, et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol. 2002;168:2953–2962
  35. Minshall EM, Leung DY, Martin RJ, et al. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1997;17:326–333
  36. Beum PV, Bastola DR, Cheng PW. Mucin biosynthesis: epidermal growth factor down-regulates core 2 enzymes in a human airway adenocarcinoma cell line. Am J Respir Cell Mol Biol. 2003;29:48–56
  37. Yu C, Cantor AB, Yang H, et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med. 2002;195:1387–1395
  38. Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305:1776–1779
  39. Huaux F, Liu T, McGarry B, et al. Dual roles of IL-4 in lung injury and fibrosis. J Immunol. 2003;170:2083–2092
  40. Lee CG, Homer RJ, Cohn L, et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem. 2002;277:35466–35474
  41. Wallace WA, Ramage EA, Lamb D, et al. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol. 1995;101:436–441
  42. Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312–1319

 Supported in part by grants NIH RO1 DK067255 (to A.M.) and NIH R01 AI45898 and NIH U19 AI070235 (to M.E.R.), the Digestive Disease Core Center (DDRDC) grant DK0789392, the Campaign Urging Research for Eosinophilic Disease (CURED), the Food Allergy Project, and the Buckeye Foundation.

PII: S0016-5085(07)01799-4

doi: 10.1053/j.gastro.2007.10.002

Gastroenterology
Volume 134, Issue 1 , Pages 204-214 , January 2008

Article Tools

* Image Usage & Resolution